https://scholars.lib.ntu.edu.tw/handle/123456789/414779
標題: | Patient derived induced pluripotent stem cells for models of cancer and cancer stem cell research | 作者: | H. M. Chao E. Chern |
關鍵字: | Cancer stem cell; Cell reprogramming; Induced pluripotent stem cells (iPSCs); Tumorigenesis | 公開日期: | 2018 | 卷: | 117 | 期: | 12 | 起(迄)頁: | 1046 1057 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Induced pluripotent stem cells (iPSCs) are embryonic stem cell-like cells reprogrammed from somatic cells by four transcription factors, OCT4, SOX2, KLF4 and c-MYC. iPSCs derived from cancer cells (cancer-iPSCs) could be a novel strategy for studying cancer. During cancer cell reprogramming, the epigenetic status of the cancer cell may be altered, such that it acquires stemness and pluripotency. The cellular behavior of the reprogrammed cells exhibits dynamic changes during the different stages of reprogramming. The cells may acquire the properties of cancer stem cells (CSCs) during the process of reprogramming, and lose their carcinogenic properties during reprogramming into a cancer-iPSCs. Differentiation of cancer-iPSCs by teratoma formation or organoid culturing could mimic the process of tumorigenesis. Some of the molecular mechanisms associated with cancer progression could be elucidated using the cancer-iPSC model. Furthermore, cancer-iPSCs could be expanded in culture system or bioreactors, and serve as cell sources for research, and as personal disease models for therapy and drug screening. This article introduces cancer studies that used the cell reprogramming strategy. ? 2018 |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/414779 | ISSN: | 0929 6646 | DOI: | 10.1016/j.jfma.2018.06.013 | SDG/關鍵字: | transcription factor; transcription factor; breast cancer; cancer model; cancer patient; cancer research; cancer stem cell; carcinogenesis; cell differentiation; cell function; colon cancer; drug screening; embryonic stem cell; gene mutation; human; induced pluripotent stem cell; leukemia; liver cancer; lung cancer; nuclear reprogramming; oncogene c myc; osteosarcoma; pancreas cancer; Review; animal; cancer transplantation; carcinogenesis; genetics; neoplasm; oncology; stem cell research; Animals; Carcinogenesis; Cell Differentiation; Cellular Reprogramming; Humans; Induced Pluripotent Stem Cells; Medical Oncology; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Stem Cell Research; Transcription Factors |
顯示於: | 生化科技學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。